miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2

被引:3
|
作者
Zhengwen Sun
Tongqing Zhang
Huanyu Hong
Qingxia Liu
Haiguang Zhang
机构
[1] Yantaishan Hospital,Department of Traumatology
[2] Yantaishan Hospital,Department of Pediatric Orthopedics
[3] Yantaishan Hospital,Department of Nursing
来源
关键词
miR-202; Gli2; Osteosarcoma; Proliferation; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Accumulating data have shown that microRNAs are involved in the pathogenesis of cancer. miR-202 has been confirmed to be downregulated in several types of human cancer. However, the expression and biological role of miR-202 in osteosarcoma (OS) carcinogenesis and progression remain unclear. In this study, we demonstrated that miR-202 expression is significantly decreased in human OS cell lines and specimens. Restoration of miR-202 expression could inhibit OS cell proliferation, induce cell apoptosis, and suppress tumor growth in nude mice models. We subsequently identified the transcription factor Gli2 as a direct target of miR-202. Overexpression of Gli2 blocked the inhibitory function of miR-202. Taken together, our results indicate that miR-202 acts as a novel tumor suppressor to regulate OS cell proliferation and apoptosis through downregulating Gli2 expression.
引用
收藏
页码:277 / 283
页数:6
相关论文
共 50 条
  • [1] miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2
    Sun, Zhengwen
    Zhang, Tongqing
    Hong, Huanyu
    Liu, Qingxia
    Zhang, Haiguang
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 397 (1-2) : 277 - 283
  • [2] MiR-202 Suppresses Cell EMT by Regulating GLI2 and Predicts Prognosis of Cervical Cancer
    Feng, Xiumei
    Zhang, Qingchun
    Xu, Qianjin
    Shao, Meiqin
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (07): : 3503 - 3514
  • [3] miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression
    Zhuang, Donghai
    Liang, Li
    Zhang, Hongzhan
    Feng, Xianguang
    ONCOLOGY RESEARCH, 2020, 28 (04) : 399 - 408
  • [4] miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb
    Gao, Yan-Fang
    Zhang, Qiu-Jie
    Yu, Zhuang
    Liu, Shi-Hai
    Liang, Jun
    ONCOLOGY LETTERS, 2018, 16 (01) : 733 - 740
  • [5] RETRACTION: miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells (Retraction of Vol 39, Pg 747, 2018)
    Wang, Nan
    Li, Pengcheng
    Liu, Wei
    Wang, Ningning
    Lu, Zhi
    Feng, Jianzhou
    Zeng, Xiandong
    Yang, Jiujie
    Wang, Yong
    Zhao, Wei
    ONCOLOGY REPORTS, 2023, 50 (01)
  • [6] miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma
    Deng, Xinchao
    Hou, Congzhe
    Liang, Zhen
    Wang, Huali
    Zhu, Lin
    Xu, Hui
    DISEASE MARKERS, 2017, 2017
  • [7] miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally
    Zhang, Yi
    Zheng, Dayong
    Xiong, Yan
    Xue, Chengbiao
    Chen, Gen
    Yan, Bibo
    Ye, Qifa
    FEBS LETTERS, 2014, 588 (10) : 1913 - 1920
  • [8] miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression
    Ren, Yuan-Fei
    Zhang, Tie-Hui
    Zhong, Sheng
    Zhao, Yan-Tao
    Lv, Ya-Nan
    ONCOLOGY LETTERS, 2018, 15 (01) : 1163 - 1169
  • [9] Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221
    Zhang, Jianjun
    Sha, Jingjing
    Zhou, Yan
    Han, Kun
    Wang, Yaling
    Su, Yang
    Yin, Xiuyi
    Hu, Haiyan
    Yao, Yang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [10] RETRACTED: miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells (Retracted article. See vol. 50, pg. 139, 2023)
    Wang, Nan
    Li, Pengcheng
    Liu, Wei
    Wang, Ningning
    Lu, Zhi
    Feng, Jianzhou
    Zeng, Xiandong
    Yang, Jiujie
    Wang, Yong
    Zhao, Wei
    ONCOLOGY REPORTS, 2018, 39 (02) : 747 - 754